Merck logo (to the Merck website)
  • Share
  • Corporate Responsibility
  • Dividend
  • Result
  • Employees
  • Sales
  • Divisions
  • Strategy
  • Executive Board
Home· | Merck Group· | Contact· | Deutsch · | Sitemap· | Search
your search: Sales
Relevance of hit 1% back to search result index | New search

  • Index
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36

Notes to the consolidated income statement Audited

  • [22] Sales
  • [23] Royalty, license and commission income
  • [24] Cost of sales
  • [25] Marketing and selling expenses
  • [26] Royalty, license and commission expenses
  • [27] Administration expenses
  • [28] Other operating expenses and income
  • [29] One-time items
  • [30] Research and development
  • [31] Amortization of intangible assets
  • [32] Investment result
  • [33] Financial result
  • [34] Income tax
  • [35] Non-controlling interest
  • [36] Earnings per share
previous hitsearch hit 33 of 57next hit

CHART GENERATOR

Interactive chart tool

SERVICES

  • Recommend page
  • Print page
  • Compare to 2011
  • Order online
  • Glossary
  • Downloads
previous hitsearch hit 33 of 57next hit
 
Imprint, © Merck KGaA, Darmstadt, Germany, Last Update 2013/03/07
  • To our Shareholders
    • Business Development 2008-2012
  • Group Management Report
    • Merck at a glance
      • Our divisions
        • Merck Serono
        • Consumer Health
        • Performance Materials
        • Merck Millipore
      • Company strategy
    • Economic Situation
    • Financial Position and Results of Operations
      • Business development
      • Expenses
      • Result
      • Quarterly performance 2012
    • Merck Serono
      • Business development
      • Regions
      • Major products
      • Therapeutic areas
    • Consumer Health
      • Business development
      • Regions
      • Brands
    • Performance Materials
      • Business development
      • Regions
    • Merck Millipore
      • Business development
      • Regions
      • Business units
    • Corporate and Other
    • Risk Report
      • Business-related risks
    • Report on Expected Developments
      • Sector
      • Forecast for sales and operating result
      • Merck Serono
      • Consumer Health
      • Performance Materials
      • Merck Millipore
      • Summary
  • Corporate Governance
    • Report of the Supervisory Board
  • Financial Statements
    • Income Statement
  • Notes
    • Scope of consolidation
      • Changes in the scope of consolidation
    • Accounting policies
      • Accounting and measurement principles
      • Consolidation methods
      • Recognition of sales and other revenue
      • Financial instruments: Principles
    • Notes to the consolidated income statement
      • Sales
      • Cost of sales
      • Marketing and selling expenses
      • One-time items
    • Notes to the balance sheet
      • Current financial assets
      • Trade accounts payable
    • Segment reporting
      • Information by division/country and region
      • Segment reporting
    • Other disclosures
      • Derivative financial instruments
      • Personnel expenses/Headcount
      • Material costs
  • The road to tomorrow
    • Committed
made by Nexxar - your next annual report online!, Vienna - Austria